Ph.D

Rapport Therapeutics filed an S1 on May 17th to go public. The genesis of Rapport Therapeutics is unequivocally linked to an effort to stop the Cassava Sciences Alzheimer's therapy trial. They seemed to put a competitor through HELL to gain an advantage and profit from a short position in the stock. David Bredt founded Rapport Therapeutics a Delaware on February 11 2022, the same day that his citizen's petition against $sava was denied by the FDA. I believe David Bredt, @JNJNews, Rapport Therapeutics, Jordan Thomas, and @ThirdRockV participated in a massive fraud to stop a competitor in the exact same research area of Receptor Associated Proteins (the RAP in Rapport). David Bredt departed Johnson and Johnson in March of 2021. He worked with Jordan Thomas and filed a Citizen's Petition and Whistleblower complaints against Cassava in August of 2021. The Citizen's Petition was denied on the same day he started Rapport. SEC and DOJ investigations still linger with no charges against $sava. How could that happen if all these events are not linked by collusion between these people and companies? @joewalkerWSJ sec.gov/Archives/edgar…

@ACInvestorBlog Believer now that Sava ain’t no trade, but a hodl 💣

$SAVA got a $131 PT at HCW this morning. Breakout watch 24.12 / Company has a SI over 30% and a SR over 22 (Days to cover).

@TheRoaringKitty Don't Miss the $SAVA ride. Sanford Robinson the Legend of WS has over 2% ownership of the Alzheimer's Drug Company and filed Form 4 yesterday for housekeeping before FDA approval.

@cpiller @corinnepurtill @NewsfromScience This as well as $SAVA will blow up in your and your conspirators ugly faces! 💣

Star USC scientist faces scrutiny — retracted papers and a paused drug trial: @corinnepurtill follows up on my 2023 @NewsfromScience investigation about work by neuroscientist Berislav Zlokovic latimes.com/science/story/…

@charliebilello Take a closer look at $SAVA not a meme real deal gigantic phase 3 asset!

Meme Stock returns: Monday-Tuesday/Weds-Thurs GameStop $GME: +179%/-43% AMC $AMC: +135%/-32% Koss $KOSS: +92%/-23% Virgin Galactic $SPCE: +33%/-19% Clover Health $CLOV: +24%/-8% Blackberry $BB: +20%/-13% Cassava $SAVA: +15%/-8% Beyond Meat $BYND: +12%/-10% SoFi $SOFI: +8%/-5%

@ACInvestorBlog Don’t trade Sava, own it. Their data is real deal and will destroy MABs treatments from Lly and biib. Thats why hedgefunds have been trying to stop Sava.

$SAVA is now back on my short squeeze WL exactly because I remember that week. With 30% float short (and we never know exactly the naked short selling or not here) plus the huge short ratio of 22 a new squeeze could be epic. Let’s wait and see how it plays out here. Disclosure: I bot shares yest and added more today for a swing trade. Do your own DD (risky trade)

@ACInvestorBlog Indeed, the bottom of barrel humanity (hedgefunds) have been shorting $SAVA for over 3 years based on hoax allegations against a company trying to bring the greatest innovation to treat Alzheimer’s. Tic toc by year end! 💣

$SAVA What a beautiful close. Big bullish candle on volume. Look at these numbers: SHORT INTEREST 34% with a SHORT RATIO of 17 (yes, 17 days to cover)

@Augustus4T @TheRoaringKitty Real deal $SAVA gonna explode and save lives at the same time! No better stonk! SAVage forever!

@TheRoaringKitty Join forces with the 1000s of SAVAges that are fight for Alzheimer’s! Shorts funds in $SAVA have : Filed a false CP Paid numerous news outlets to publish false articles. Complained to SEC Complained to FDA Complained to DOJ no actions, now Sava will be reading out phase 3

@EndAlzFraud huh? Which endpoint failed? All data has shown amazing trends in cognition. Another lie? 🤡

$SAVA lol

@ChampyRobert All of them are a bunch of 🤡s And cowards. Soon to be hiding even further after Sava Phase 3 readout in Q4 of this year

What's the deal with these ridiculous portraits these $sava critic ego maniacs use to portray themselves? Legends in their own minds, I guess. WTF are you looking at in your black and white selfie, Rob? You dream boat 🤡

@AD3ENDALZ @Vinnie66007649 @adamfeuerstein i suspect this twat fudstain will get sued many times over…👌

@Vinnie66007649 Lol only talks about a bonus incentive that not a single director FROM $SAVA ever touched a 1$ and simu pivoting . Does this jerk head knows from what Pfizzer viagra/sildenafil actually pivoted from ? and being one of the best selling drug of all time ? F.him! @adamfeuerstein

⁦Too bad this self proclaimed Harry King of Biotech blocked me. Using overwhelming “evidence”, he can’t differentiate evidence vs allegations. What evidence he has? Why DOJ/ SEC have no actions against $SAVA? What happens when Simufilam is approved to all the 🤡 🤡 🤡?

@EndAlzFraud Huh? Are you describing the paid bashers that have attack sava with everything and kitchen sink for iver 3 years….🤡

it becomes easier to understand $SAVA when you realize it is a dozen people with narcissistic personality disorder and no ethical compass

@PatricioMarceso @AD3ENDALZ @ProfRobHoward How does a pico-femto molar biological activity sound, like ginseng? 🤡

@AD3ENDALZ @ProfRobHoward Look, I understand you are desperate and I actually feel for you. We would really badly need some kind of working medication for Alzheimer's. But facts are facts and they speak for themselves here. Hope you will be able to appreciate them one day. Good luck to you & your family!

Always cheering when a fan reaches out.

@AnaximanderQQ @ProfRobHoward @shakespeare34 on point!

@ProfRobHoward Let’s be honest, you chose the wrong profession and career and are jealous of those that finally succeed in Alzheimer’s, amirite?

@Rick_in_Miami @CassavaSciences It’s not new, it’s been posted for a few weeks now

$SAVA This NEW Phase 1 trial indicates company is getting ready for approval as they are testing Simufilam in population with impaired Liver/Kidney. Normally this is last minute study for drugs near Ph3 approval. clinicaltrials.gov/study/NCT06390… @CassavaSciences

@arkabagchi24 This post is a whole lot of bullshit. give my condolences to your toast short employers 🔥🥳

$SAVA fan pulling the “you are willing to let people die” line while vehemently supporting a company peddling bullshit research and a bullshit drug that is literally misleading patients into wasting the latter months of their lives and letting people die

@MattNachtrab The shorts know 100% that the drug works. They were simply putting pressure on the company to fail….but it is they that have failed.

The additional 5 million shares of float, added to $sava with the warrant program will provide more ammunition to shorts as well. Before the redemption shorts had maxed out available shares. If you don’t want shorts to borrow your shares, put them in a cash account. We know the shorts are convinced the drug doesn’t work or they desire to prevent the company from launching a successful treatment for #Alzheimers. We know they will stop at nothing in that pursuit. So if they can borrow, they will max it out and drop the price.